J. Morris

419 total citations
7 papers, 327 citations indexed

About

J. Morris is a scholar working on Pulmonary and Respiratory Medicine, Hepatology and Surgery. According to data from OpenAlex, J. Morris has authored 7 papers receiving a total of 327 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Pulmonary and Respiratory Medicine, 3 papers in Hepatology and 2 papers in Surgery. Recurrent topics in J. Morris's work include Hepatocellular Carcinoma Treatment and Prognosis (3 papers), Liver Disease Diagnosis and Treatment (2 papers) and Gastric Cancer Management and Outcomes (2 papers). J. Morris is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (3 papers), Liver Disease Diagnosis and Treatment (2 papers) and Gastric Cancer Management and Outcomes (2 papers). J. Morris collaborates with scholars based in United States and Egypt. J. Morris's co-authors include Jerrold M. Milstein, Edward J. Kosnik, W. Archie Bleyer, J. Timothy Stuntz, Richard L. Heideman, J. Russell Geyer, F. B. Ruymann, Thomas W. Pendergrass, Arlynn F. Mulne and Ahmed O. Kaseb and has published in prestigious journals such as Journal of Clinical Oncology, Gastroenterology and Cancer.

In The Last Decade

J. Morris

7 papers receiving 316 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J. Morris United States 4 153 117 101 89 82 7 327
Micaela Motta Italy 10 108 0.7× 76 0.6× 32 0.3× 79 0.9× 79 1.0× 20 301
E. Vasario Italy 9 208 1.4× 131 1.1× 77 0.8× 88 1.0× 35 0.4× 13 343
Marie‐Laure Brisson Canada 10 67 0.4× 90 0.8× 73 0.7× 34 0.4× 40 0.5× 11 308
Catherine R. García United States 10 139 0.9× 106 0.9× 43 0.4× 79 0.9× 49 0.6× 23 327
R. A. Abrams United States 7 162 1.1× 83 0.7× 208 2.1× 58 0.7× 48 0.6× 11 358
F. Thillays France 11 170 1.1× 281 2.4× 59 0.6× 142 1.6× 70 0.9× 42 422
Takayuki Tokunaga Japan 9 38 0.2× 53 0.5× 93 0.9× 79 0.9× 77 0.9× 51 250
Hendrik Blaeker Germany 8 70 0.5× 32 0.3× 211 2.1× 111 1.2× 67 0.8× 14 323
Andy Gillespie United States 9 143 0.9× 213 1.8× 214 2.1× 43 0.5× 78 1.0× 13 468

Countries citing papers authored by J. Morris

Since Specialization
Citations

This map shows the geographic impact of J. Morris's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Morris with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Morris more than expected).

Fields of papers citing papers by J. Morris

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Morris. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Morris. The network helps show where J. Morris may publish in the future.

Co-authorship network of co-authors of J. Morris

This figure shows the co-authorship network connecting the top 25 collaborators of J. Morris. A scholar is included among the top collaborators of J. Morris based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. Morris. J. Morris is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Pestana, Roberto Carmagnani, Manal M. Hassan, Reham Abdel‐Wahab, et al.. (2018). Clinical and prognostic significance of circulating levels of angiopoietin-1 and angiopoietin-2 in hepatocellular carcinoma. Oncotarget. 9(102). 37721–37732. 15 indexed citations
2.
Kaseb, Ahmed O., Reham Abdel‐Wahab, Ravi Murthy, et al.. (2017). A Phase II study of sorafenib and yttrium-90 glass microspheres for advanced hepatocellular carcinoma, BCLC stage C. Annals of Oncology. 28. v242–v242. 1 indexed citations
3.
Abaza, Yasmin, Reham Abdel‐Wahab, Donghui Li, et al.. (2016). Association between the job types and the risk of hepatocellular carcinoma in the United States. 3(1). 2 indexed citations
4.
Hassan, Manal M., Reham Abdel‐Wahab, Ahmed O. Kaseb, et al.. (2015). Obesity Early in Adulthood Increases Risk but Does Not Affect Outcomes of Hepatocellular Carcinoma. Gastroenterology. 149(1). 119–129. 73 indexed citations
5.
Ajani, Jaffer A., Garrett L. Walsh, Ritsuko Komaki, et al.. (2004). Preoperative induction of CPT‐11 and cisplatin chemotherapy followed by chemoradiotherapy in patients with locoregional carcinoma of the esophagus or gastroesophageal junction. Cancer. 100(11). 2347–2354. 54 indexed citations
6.
Chirieac, Lucian R., Yutaka Suehiro, Antti Niemistö, et al.. (2004). Size and number of examined lymph nodes impacts outcome in patients with stage II colorectal cancer. Journal of Clinical Oncology. 22(14_suppl). 3507–3507. 1 indexed citations
7.
Pendergrass, Thomas W., Jerrold M. Milstein, J. Russell Geyer, et al.. (1987). Eight drugs in one day chemotherapy for brain tumors: experience in 107 children and rationale for preradiation chemotherapy.. Journal of Clinical Oncology. 5(8). 1221–1231. 181 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026